Elevance Health Revises 2025 Earnings Guidance Due to Elevated Medical Costs and Medicaid Rate Delays
Elevance Health (ELV) revised its full-year 2025 adjusted EPS guidance to approximately $30, citing elevated medical cost trends in ACA and slower-than-expected Medicaid rate alignment. The company's CFO noted a 2.6 percentage point increase in the benefit expense ratio, driven by ACA and Medicaid segments, with a prolonged margin recovery period anticipated for Medicaid.
Tickers: $ELV
Topics: Earnings Guidance EPS Revision Medicaid Rate Alignment Medical Cost Trends